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Abstract 
Background 
The effectiveness and efficiency of nursing-home dementia care are suboptimal: there are high 
rates of neuropsychiatric symptoms among the residents and work-related stress among the 
staff. Dementia-care mapping is a person-centred care method that may alleviate both the 
resident and the staff problems. The main objective of this study is to evaluate the effectiveness 
and cost-effectiveness of dementia-care mapping in nursing-home dementia care.  
Methods/Design 
The study is a cluster-randomised controlled trial, with nursing homes grouped in clusters. 
Studywise minimisation is the allocation method. Nursing homes in the intervention group will 
receive a dementia-care-mapping  intervention, while the control group will receive usual care. 
The primary outcome measure is resident agitation,  to be assessed with the Cohen-Mansfield 
Agitation Inventory. The secondary outcomes are resident neuropsychiatric symptoms, 
assessed with the Neuropsychiatric Inventory – Nursing Homes and quality of life, assessed 
with Qualidem and the  EQ-5D. The staff outcomes are stress reactions, job satisfaction and  
job-stress-related absenteeism, and staff turnover rate, assessed with the Questionnaire about 
Experience and Assessment of Work,  the General Health Questionnaire-12, and the Maastricht 
Job Satisfaction Scale for Health Care, respectively. We will collect the data from the 
questionnaires and electronic registration systems. We will employ linear mixed-effect models 
and cost-effectiveness analyses to evaluate the outcomes. We will use structural equation 
modelling  in the secondary analysis to evaluate the plausibility of a theoretical model 
regarding the effectiveness of the dementia-care mapping  intervention. We will set up process 
analyses, including focus groups with staff, to determine the relevant facilitators of and barriers 
to implementing dementia-care mapping  broadly. 
Discussion 
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A novelty of dementia-care mapping is that it offers an integral person-centred approach to 
dementia care in nursing homes. The major strengths of the study design are the large sample 
size, the cluster-randomisation, and the one-year follow-up. The generalisability of the 
implementation strategies may be questionable because the motivation for person-centred care 
in both the intervention and control nursing homes is above average. The results of this study 
may be useful in improving the quality of care and are relevant for policymakers.  
Trial registration 
The trial is registered in the Netherlands National Trial Register: NTR2314. 
 
Background 
The prevalence of neuropsychiatric symptoms among nursing-home residents with dementia is 
about 80% [1-4]. In addition to directly affecting the residents’ quality of life, these symptoms 
represent a serious challenge to professional caregivers [5,6]. Staff job dissatisfaction results in 
high illness absenteeism (5.4%) and turnover rates, which ultimately leads to staff shortages [7-
13]. A strong relationship has been found between high staff turnover and poor resident 
outcomes such as quality-of-care deficiencies, quality-of-life deficiencies, use of psychoactive 
drugs, and drug-induced hospital admission due to serious adverse events [6,8,14,15]. These 
facts suggest that the current efforts put into dementia care leave room for improvement in 
quality and cost-effectiveness of care. In order to provide optimal dementia care, the staff often 
needs additional training [13,16-18]. Dementia-care mapping (DCM) is a multicomponent 
intervention, which was developed by the Dementia Research Group at Bradford University, 
UK, in 1992, and is based on Kitwood’s social-psychological theory of personhood in dementia 
[19]. This theory posits that much of the ill-being that people with dementia experience is due 
to negative environmental influences, including staff attitudes and care practices. Dementia-
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care mapping assists staff in identifying the triggers causing the well-being and ill-being of 
people with dementia [20]. 
Dementia-care mapping offers an integral, person-centred approach to dementia care. 
Many other interventions based on person-centred care, such as multimodal sensory stimulation 
(snoezelen) [14,21] and person-centred bathing [22,23] have a more limited scope. These 
interventions aim either at residents or at staff alone, and while they are very valuable in their 
own right, they are limited to psychosocial aspects of care or they apply in a single care-giving 
situation such as bathing. These interventions often do not include systematic adaptations in 
management style and organisational climate. We can expect single-scope interventions, 
usually aimed either at staff, residents, management style, or organisational climate alone, need 
to operate synergistically if we are to sustainably improve effectiveness, efficiency, and quality 
of dementia care in nursing homes. Dementia care experts recommend using a range of 
interventions that address the needs of both residents and staff [24]. The aims of this study are 
to reduce the frequency and intensity of neuropsychiatric symptoms, improve the quality of life 
of dementia patients, improve staff-resident interactions and staff job satisfaction, and reduce 
job-related stress by means of the introduction of the DCM method in dementia care. We will 
use a cost-effectiveness analysis to determine whether the intervention positively affects the 
efficiency of care.  
 
Methods/Design 
Study design and setting  
The study is a cluster-randomised, controlled trial (Figure 1). We will evaluate the DCM 
intervention in Dutch nursing homes, which will be clustered. We will use cluster-
randomisation in order to avoid contamination with the effects of possible exchange of 
information within a cluster. We will use a studywise minimisation method [25] to allocate the 
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clusters (units) to either the intervention group or the control group. Nursing homes in the 
intervention group will receive DCM training and a DCM organisational briefing day. Care will 
be evaluated in two DCM cycles of observation, feedback, and action plans. Quantitative 
methods will be used to study effectiveness and efficiency, and qualitative methods will be 
used to conduct a process analysis and to study facilitators of and barriers to broader 
implementation of DCM in daily practice. The ethical committee Arnhem-Nijmegen waived 
approval for this study (registration number 2010/147). 
 
Study sample 
The study sample will consist of residents with dementia from nursing-home dementia special-
care units (DSCUs) and their formal caregivers. Now, at the time of writing, the nursing homes 
have been recruited. This was done in several ways: e.g. advertising on the Dutch DCM 
website (http://dcmnederland.nl/), the VENVN website (the website of a Dutch professional 
organisation for nursing personnel), and invitational letters to nursing homes with information 
about the project. 
We recruited 34 DSCUs from 11 nursing home organisations. The participating nursing 
homes serve several regions in the Netherlands. A DSCU is defined as a residential unit with 
common areas and staff. This can be a group in a small-group residential facility or a DSCU in 
a nursing home. The number of patients in a DSCU can range from 3 to 32. The participating 
DSCUs will provide residence for at least 250 people. The inclusion criteria for the residents 
are  as follows:  
• Age of 65 years or more 
• Dementia diagnosed by an elderly-care physician according to the Diagnostic and 
statistical manual of mental disorders-IV criteria for dementia [26] 
• Approval of the elderly-care physician for inclusion 
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• At least one of the following neuropsychiatric symptoms: aggression, motor or verbal 
agitation, psychosis, depression, and apathy 
• Informed consent given by  the residents themselves, their families, or their legal 
guardians 
• The resident must use the common areas, such as the shared living room, at least 4 
hours a day. 
Residents with an estimated life expectancy of 6 weeks, or those who are physically unable to 
spend time in common areas of the facility, will not be included in the study. If residents 
withdraw their consent for any reason or develop a life-threatening disease, they will be 
excluded from the study. Evidence shows that the attrition rate is relatively high in this kind of 
population, so, to allow for intention-to-treat analysis, we will replace any participants  lost to 
follow-up with new participants. 
 
Bias control and randomisation 
Randomisation will take place after the study sample has been recruited and informed consent 
has been given, but before the DCM training, the DCM organisational briefing day, and the 
start of the intervention. The clusters will be randomised to avoid contamination by the effects 
of possible exchange of information within a nursing home. The dementia care mappers will be 
recruited from DSCUs other than those where the DCM cycles will take place. The reason for 
this is that the DCM observations and feedback should not be influenced by professional or 
personal relationships. The minimisation method will be used for randomisation [25] to assure 
an equal distribution of baseline characteristics to the intervention and control groups. This 
means that nursing homes will be randomised with the aid of adaptive weights based on the 
sizes of the nursing homes, DSCU sizes and the formal caregiver-to-resident ratios. Nursing 
homes will be randomly allocated to one of  two conditions: the DCM intervention and usual 
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care. A person who has no knowledge of and no relationship to the study will do the 
randomisation with appropriate software to assure allocation concealment.  
Because of the DCM training and intervention, the study cannot be blinded with respect 
to nursing homes, residents, and their caregivers. The researcher (GV), the research assistant 
(FB), and the DCM trainer (AP) will not be blinded to this information.  
 
Intervention 
The Bradford Dementia Group [27] developed the DCM method, which is based on the 
principles of person-centred care [28,29]. The DCM method is an observational tool that has 
been used in formal dementia care settings since 1992, both as an instrument for developing 
person-centred care practice, and as a tool in evaluative research [20,30,31]. Dementia-care 
mapping  is a method in which care improvement plans (action plans) are based on systematic 
observations of the actual care as it takes place in formal settings such as nursing homes and 
day care. The feedback to the staff is expected to raise their awareness regarding the 
interdependency of their own behaviour and that of the residents. The feedback occurs in a 
nonthreatening way and does not serve as staff-evaluation tool. The fact that not only 
‘negative’ but also ‘positive’ events are recorded and brought to light motivates staff to 
improve their competences and performance. Dementia-care mapping offers a set of tools for 
personal and organisational development. Through DCM, the staff may attain an important 
signalling role towards the members of the multidisciplinary care teams in nursing homes 
(which include psychologists, elderly-care physicians, regular physicians, physiotherapists, and 
occupational therapists). This allows for the timely initiation of tailor-made psychological or 
other interventions [32], which is very important in ensuring long-term positive effects of 
DCM. Furthermore, it is important to emphasise that the DCM method acts as a channel for the 
timely implementation of various kinds of improvements for  individuals (residents and 
caregivers) groups (professional development needs), DSCUs, multidisciplinary teams, 
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management, and organisations.  This way, the improvement actions become well coordinated 
and sufficiently individually tailored.  
 
Intervention components of dementia-care mapping  
Phase 1:  training in dementia-care mapping 
Staff members of intervention nursing homes will receive DCM training. A basic DCM user 
needs a 4-day course of basic concepts and skills. A basic user can participate in a DCM team 
under the supervision of an advanced user. To become an advanced user, a staff member must 
also take a 3-day course about the background and theory of DCM. Advanced users can map 
care, report observations, lead a DCM team, give feedback to the staff, and instruct and support 
them in drawing up action plans. At least one staff member in each organisation will become an 
advanced user. 
 
Phase 2: organisational briefing day for dementia-care mapping 
At the end of the DCM training, intervention nursing homes will be visited and will receive a 
one-day training course. This course provides organisation-wide basic understanding of the 
DCM method to ensure endorsement of DCM goals and methods and to aid its implementation 
in an organisation or setting. 
 
Phase 3: two dementia-care mapping cycles: observations–feedback–action plan  
After completing the DCM training and the DCM organisational briefing day, the intervention 
nursing homes will carry out two DCM cycles.  A single DCM cycle (Figure 2) consists of:  
 
1. Observation. An observer (mapper) continuously observes an average of five (four to six) residents 
with dementia for a representative period (a minimum of 4 h/day) in communal areas (living rooms or 
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common rooms) of care facilities. After each 5-min period (a time frame) a coding protocol will be used 
to record what has happened to each participant and what the behaviour of the staff was [20,30].    
Dementia-care mapping employs behavioural category codes (BCCs), well/ill-being (WIB) values, 
personal detractions (PDs), and personal enhancers (PEs) to code this behaviour (Figure 3).    
 
2. Feedback. The results of the observation are fed back to the staff. The positive 
communication style of the feedback enables them to interpret it in the context of the residents’ 
lives rather than relating it to themselves in a negative way. The feedback style enables the staff 
to form a more complete picture of the residents and prevents resistance to negative feedback 
or unwillingness to change their personal style of care.   
 
3. Action plans. The staff draw up action plans for care improvements at an individual level and 
a group level on the basis of feedback discussions. Action plans are tools for implementing the 
principles of person-centred care in daily practice.  
 
Control group 
Caregivers in the control group will receive neither the DCM training nor the DCM 
organisational briefing day. The control group residents will continue to receive usual care 
during the trial. To motivate these nursing homes to complete the measurements, a researcher 
will visit each control nursing home at the start of the trial, and the control nursing homes will 
receive the DCM training after the trial.  
 
Measurements  
The study outcome variables will be measured at the resident and staff levels. The primary 
outcome measure is resident agitation, to be assessed with the Cohen-Mansfield Agitation 
Inventory (CMAI). This questionnaire consists of 29 items about agitation and aggression in 
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residents with dementia, and it has been validated for use in the Netherlands [33,34]. The 
secondary outcome measures are the residents’ other neuropsychiatric symptoms, to be 
assessed with the Neuropsychiatric Inventory – Nursing Homes (NPI-NH), a comprehensive 
neuropsychiatric rating scale including the following symptoms: delusions, hallucinations, 
agitation, depression, anxiety, euphoria,  apathy, disinhibition, irritability, aberrant motor 
behaviour, night-time disturbances and eating change [35]. The residents’ quality of life will be 
measured with Qualidem [36] and EQ-5D [37]. We will use the Global Deterioration Scale 
(GDS) to obtain information about dementia severity [38]. Such information will include fall 
incidents, physical restraints, and the amount of care delivered, which is recorded in the 
nursing-home administration system. A questionnaire about the resident demographics at 
baseline has been developed for our study, and it includes the following variables: age, sex, 
marital status, highest completed education, country of origin, longest former profession, and 
co-morbidity. 
The following staff outcome measures will be collected: stress-related symptoms, job 
experience, job satisfaction, job-stress-related absenteeism, and employee turnover. We will 
use the General Health Questionnaire (GHQ-12) to measure stress-related symptoms. This 
validated instrument consists of 12 questions, and it is sensitive for measuring changes in 
general health [39,40]. We will also use two validated Dutch questionnaires: the Questionnaire 
about Experience and Assessment of Work (QEAW) and the Maastricht Job Satisfaction Scale 
for Healthcare (MJSS-HC) [41,42]. The questionnaire about staff demographics at baseline was 
developed for the present study and consists of the following variables: age, sex, marital status, 
highest completed education, country of origin, and experience with person-centred care.   
All staff members of the participating units will be asked to fill in questionnaires about 
themselves (MJSS-HC, QEAW, and GHQ-12). Any staff member who is the caregiver 
primarily responsible for a particular resident will also be asked to fill in questionnaires about 
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the resident (CMAI, NPI-NH, Qualidem, EQ-5D and GDS; Table 1). The staff  will use an 
internet application with a personal user name and password to fill in these questionnaires. All 
the variables will be measured at baseline (T0), after the first DCM cycle (T1), and after the 
second DCM cycle (T2). 
Quantitative and qualitative methods will be used in process analyses. Quantitative 
process analyses will help account for the possible differences in intervention ‘dosage’ that 
might moderate the effects of the DCM. Qualitative process analyses will be used to determine 
relevant facilitators of and barriers to further implementation.  
 
Economic data 
The cost-effectiveness of the intervention will be calculated and compared to usual practice. 
Table 1 shows the various data sources for the assessment of resource use, direct costs and staff 
productivity losses. We ask all organisations and residents (or their family or legal guardian) 
permission to extract data from the nursing-home administration system. Intervention costs,  
including costs for the DCM training, will be estimated. Study-specific costs, which would not 
occur in routine application, will not be considered.  
 
Sample size calculations  
The calculation of the sample size calculation includes two steps: 
 
1. Chenoweth et al. [43] report that the  treatment–control difference was 10.9 in their recent 
cluster-randomised controlled trial, which had with five units in the control group and five in 
the DCM group, a 20% attrition rate in 8 months, and an average of 14 evaluable patients at 
follow-up. As the 95% confidence interval of the mean difference was 0.7 – 21.1, the standard 
error of the difference was approximately (21.1- 0.7)/4 = 5.1. Therefore, a study with a similar 
attrition rate, standard deviation, cluster (unit) sizes, interclass correlation coefficient (ICC), 
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analysis method and design, but with nine clusters per arm, would have a standard error of 
difference of approximately 5.1√(5/9) = 3.8. For a true difference between the treatments of 
10.9, the power of such a study would be 80% (two-sided testing at alpha = 0.05). 
 
2. In our study, we plan to include at least five organisations in the control group and at least 
five organisations in the intervention group, with an average of three units in each organisation. 
Due to the correlation, the ‘effective’ sample size for each arm will be  
 
)](
)1(1[
onorganisatiwithinunitsofncorrelatio
onorganisatiperunitsofnumber
armperunitsofnumber
×
−+
 
 
Allowing the correlation between units within a organisation to be 0.3 at most (which is a safe 
margin), we would need 15 units/arm to have an ‘effective’ sample size of 9 units/arm. Using 
step 1, we conclude that, with at least 15 units/arm, along with an attrition rate, standard 
deviation, cluster (or unit) size, and an ICC (for patients within a unit) similar to those of 
Chenoweth et al. [43], we would have 80% power to detect a true difference of 10.9 between 
the treatment group and the control group. 
 
Statistical analyses 
The effects on the primary outcome will be evaluated by means of linear mixed-effect models 
with treatment, baseline measures, and control variables (used in the sequential balancing 
minimisation procedure [25]) as covariates and the DSCU as a random effect, to correct for 
dependencies within DSCUs. We use intention to treat analysis and subgroup analysis were we 
compare the observed patients with the control group. We will use structural equation 
modelling in the secondary analysis to evaluate the plausibility of a theoretical model including 
a number of mediator variables (WIB and PE/PD). We will use quantitative methods to study 
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the effectiveness, efficiency, and factors that can influence the implementation of DCM in the 
organisation. We intend to evaluate focus groups and determine relevant facilitators of and 
barriers to implementation by means of qualitative methods. 
 
Economic evaluation 
The cost-effectiveness analyses focus on the addition of the DCM intervention to nursing 
homes and comparing it to usual care from a societal perspective. On the basis of the above-
mentioned outcomes, two different incremental cost-effectiveness ratios (ICERs) will be 
computed: costs per quality-adjusted life year gained (by residents) and costs per increase in 
scores on staff job satisfaction measure (MJSS-HC). Other outcome measures such as 
neuropsychiatric symptoms and volumes of care, work stress, stress-related absenteeism and 
staff turnover will be financially valued and included in the ICER on the cost side. Cost-
effectiveness will be analysed in a Bayesian fashion, i.e. we will derive an acceptability curve 
that can evaluate efficiency in a set of increasing thresholds for the denominators of the ICERs. 
Furthermore, cost-effectiveness analysis will be accompanied by the value of the  information 
analysis. 
 
Discussion 
A strength of DCM is that it offers an integral person-centred approach to dementia care in 
nursing-home settings. In addition to psychosocial interventions (action plans) focusing on 
individual staff members and residents, DCM also induces systematic adaptations in 
management style and organisation climate. We can expect that all these conditions need to 
operate synergistically if we are to sustainably improve effectiveness, efficiency, and quality of 
dementia care in nursing homes. 
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The major strengths of the study design are the large sample size, cluster randomisation, 
and a follow-up of 1 year. We will randomise clusters after recruiting the study sample and 
seeking informed consent from the residents. In this way, we can control for potential selection 
bias in the control and intervention groups. We will use the minimisation method for 
randomisation to assure an equal distribution of baseline characteristics. However, it is possible 
that both the intervention and the control nursing homes in our study are more than averagely 
motivated to implement person-centred care. Any implementation strategies developed on the 
basis of our findings may therefore have suboptimal generalisability. However, in this respect, 
no differences are to be expected between the intervention and the control groups. The effect of 
the DCM intervention could perhaps be underestimated because nursing home organisations in 
the control group may already have a more positive attitude towards person-centred care than 
the average nursing-home organisation in the Netherlands. We will collect data from previous 
person-centred-care track records for all nursing homes in the study. 
In this study, we will first train the staff from the intervention nursing homes before 
taking baseline measurements. The purpose of this is to minimise the attrition rate; the period 
from the start of the training and the end of the first DCM cycle is 9 months. Due to the 
decision to train the staff before the baseline measurement, it is conceivable that training might 
affect the behaviour of the trained staff member in that he or she may already start applying the 
principles of person-centred care in daily practice. Obviously, this could influence care giving 
in the intervention nursing homes before the baseline measurement. In order to attenuate 
contamination, the staff will be instructed not to disclose or try to implement the DCM method 
or person-centred care until the organisational briefing day has taken place. Possible baseline 
differences will be accounted for by their inclusion in the analyses.  
From a public health perspective, this study should provide evidence regarding  the 
effectiveness of nonpharmacological support for dementia patients in nursing homes in the 
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Netherlands. It is necessary for policymakers to make their decisions about financing new 
services on the basis of strong evidence regarding the acceptance of new interventions and their 
cost-effectiveness.  
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Table 1 – Data sources for measurements of residents and staff 
 
Residents 
Variable Instrument/source Type of variable 
Demographic variables Self-developed questionnaire Control variables 
Dementia severity  Global Deterioration Scale  Control variable 
Care needs Weight of Care Package: nursing home 
administration 
Control variable 
Agitation Cohen-Mansfield Agitation Inventory   Primary outcome/ICER 
Neuropsychiatric symptoms Neuropsychiatric Inventory – Nursing 
Homes  
Secondary outcome  
Quality of life  Qualidem and EQ-5D  Secondary outcome/ICER 
Fall incidents Nursing home administration Secondary outcome/ICER 
Physical restraints  Nursing home administration Secondary outcome/ICER 
Amount of care delivered and 
medication use 
Nursing home administration Secondary outcome /ICER 
 
Staff 
Variable Instrument/source Type of variable 
Demographic variables Self-developed questionnaire Control variables 
Stress-related symptoms General Health Questionnaire-12  Secondary outcome/ICER 
Job experience and job assessment Questionnaire about Experience and 
Assessment  of Work  
Secondary outcome/ICER 
Job satisfaction Maastricht Job Satisfaction Scale for 
Health Care  
Secondary outcome/ICER 
Stress-related absenteeism  Nursing home administration Secondary outcome/ICER  
Employee turnover Nursing home administration Secondary outcome/ICER  
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Figures Legends 
 
Figure 1 – Study design 
Figure 2 – Single cycle of dementia-care mapping 
Figure 3 – Explanation of BCC, WIB, PD’s en PE’s 
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